Puma Biotechnology (PBYI) Capital Expenditures Growth (1y) (2012 - 2025)
Puma Biotechnology (PBYI) Capital Expenditures Growth (1y) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Puma Biotechnology |
384.39 Mn |
282.84 Mn |
34.39 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-410.00% |
| Sep 30, 2025 |
160.00% |
| Jun 30, 2025 |
100.00% |
| Dec 31, 2024 |
71.01% |
| Sep 30, 2024 |
-87.50% |
| Dec 31, 2023 |
99.01% |
| Sep 30, 2023 |
-98.86% |
| Dec 31, 2018 |
-46.72% |
| Sep 30, 2018 |
131.06% |
| Jun 30, 2018 |
433.33% |
| Mar 31, 2018 |
-31.45% |
| Dec 31, 2017 |
-146.50% |
| Sep 30, 2017 |
-81.99% |
| Jun 30, 2017 |
-98.98% |
| Mar 31, 2017 |
181.82% |
| Dec 31, 2016 |
172.91% |
| Sep 30, 2016 |
-4.06% |
| Mar 31, 2016 |
-75.42% |
| Dec 31, 2015 |
-177.17% |
| Mar 31, 2015 |
4,375.00% |
